Product

HMPL-A83

Aliases

HMPL-A83 injection

1 clinical trial

1 indication

Indication

Advanced Tumors

Clinical trial

A Phase I, Multicenter, Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-A83 in Patients With Advanced Malignant Neoplasm

Status: Recruiting, Estimated PCD: 2025-06-07